News
May 19, 2026
The access timelines for rare disease medicines have increased to 801 days from 685 days as reported last year. Average access timelines for all medicines […]
March 4, 2026
A new report shows Ireland’s pharmaceutical sector is of unprecedented economic importance and national strategic value. Conclusion of IPHA Framework Agreement is a new direction […]
January 20, 2026
New four-year deal designed to deliver faster patient access to innovative medicines, within 180 days to HSE decisions on reimbursement and a stable policy framework. […]
October 8, 2025
6,000 patients could benefit from €30 million for new medicines announced in Budget 2026 Minister’s commitment to adhering to the legislative timelines for new medicines decisions […]
September 29, 2025
IPHA welcomes the confirmation today (Tuesday 29th September) from the Minister for Health, Jennifer Carroll MacNeill TD, that the State will enter into formal talks on […]
August 21, 2025
Thursday 21st August 2025 IPHA notes the joint statement by the US and EU on tariffs today (Thursday), particularly the aspects dealing with pharmaceuticals. Some mitigation […]
May 7, 2025
Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.
April 23, 2025
The objective of Directive 91/271/EEC is to protect the environment from being adversely affected byinsufficiently treated urban wastewater discharges.
February 26, 2025
Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.